The research group is an interdisciplinary forum that perform clinical trials and translational research on pancreatic cancer and pancreatic cysts. The research group studies the importance of environmental and genetic factors in cancer development, prognostic and predictive factors, early diagnosis, and the efficacy of surgical- oncological- and symptomatic treatment. Patients with pancreatic tumors treated at Oslo University Hospital is requested consent for storage of biological material and clinical data for use in research. The research group has established a clinical data registry and a biobank with an associated database. This ensures a systematic, prospective registration of patients with pancreatic cancer who are being treated at the hospital. Clinical registry contains relevant clinical and histopathological data from routine diagnostics. Biobank database contains the results of clinical and molecular research.
Short-Course or Total Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer - Current Status and Future Perspectives
Front Surg, 9, 839339
Echinococcosis in a non-endemic country - 20-years' surgical experience from a Norwegian tertiary referral Centre
Scand J Gastroenterol, 1-5 (in press)
Survival after liver resection and liver transplantation for colorectal liver metastases: a comparative analysis stratified by metabolic tumor volume assessed by 18F-FDG PET/CT
HPB (Oxford) (in press)